Literature DB >> 8770998

Management of lupus nephritis.

J E Balow1, D T Boumpas, B J Fessler, H A Austin.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8770998

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  6 in total

Review 1.  Lupus nephritis in children.

Authors:  K L Gupta
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

2.  Pulmonary thrombosis as the first manifestation of systemic lupus erythematosus in a 14-year-old boy.

Authors:  Annie Harroche; Natascha Remus; Solenn Gaubicher; Olivier Dunand; Magali Colombat; Christophe Delacourt; Fouad Madhi
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

3.  Effect of lower dose intravenous cyclophosphamide on remission induction in Korean patients with lupus nephritis.

Authors:  Sang-Seokg Seong; Chan-Bum Choi; Hye-Ryeon Yun; Yoon-Jeong Kim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2007-10-09       Impact factor: 2.631

4.  Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study.

Authors:  X W Zhang; Chun Li; X X Ma; J X Zhao; Yuan An; Shuang Liu; Yan Li; Z G Li
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

5.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

6.  Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors:  Christian Plank; Veronica Kalb; Bernward Hinkes; Friedhelm Hildebrandt; Olaf Gefeller; Wolfgang Rascher
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.